Zurcher Kantonalbank Finance (Guernsey) Limited Share Price

Certificat

Z09EQZ

CH1329124015

Market Closed - Swiss Exchange 16:20:00 02/07/2024 BST
106.2 CHF -0.23% Intraday chart for Zurcher Kantonalbank Finance (Guernsey) Limited
Current month-0.23%
1 month-1.00%
Date Price Change
02/07/24 106.2 -0.23%

Delayed Quote Swiss Exchange

Last update July 02, 2024 at 04:20 pm

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying NOVARTIS AG
Issuer ZKB
Z09EQZ
ISINCH1329124015
Date issued 18/04/2024
Strike 84.52 CHF
Maturity 22/04/2025 (292 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 107.2 CHF
Lowest since issue 101.3 CHF
Spread 5 CHF
Spread %0.47%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
108.1 USD
Average target price
110.3 USD
Spread / Average Target
+2.12%
Consensus
  1. Stock Market
  2. Certificates
  3. Z09EQZ Certificat